CAMP4 Therapeutics Corporation (CAMP) Stock

NASDAQ: CAMPHealthcare company in the biotechnology industry, based in Cambridge, MA.

CAMP4 Therapeutics stock price chart

CAMP interactive chart →

CAMP stock quote & key statistics

CAMP4 Therapeutics earnings per share

Income →
Earnings per share

CAMP4 Therapeutics revenue & net income

Income →
RevenueNet income

CAMP4 Therapeutics annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$3.5M-$80.4M-$2.01
FY2024$652,000-$51.8M-$73.89
FY2023$350,000-$49.3M—
FY2022$294.9M-$32.5M—
FY2021$295.8M-$28.0M—

Fiscal year ending December 31. Source: company filings via EODHD.

About CAMP4 Therapeutics Corporation

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

CAMP4 Therapeutics stock FAQ

What is the CAMP4 Therapeutics stock ticker symbol?

CAMP4 Therapeutics Corporation trades on the NASDAQ under the ticker symbol CAMP.

What sector and industry is CAMP4 Therapeutics in?

CAMP4 Therapeutics Corporation is classified in the Healthcare sector, Biotechnology industry.

How many employees does CAMP4 Therapeutics have?

CAMP4 Therapeutics Corporation has about 48 full-time employees.

What were CAMP4 Therapeutics's revenue and earnings last fiscal year?

CAMP4 Therapeutics reported revenue of $3.5M and net income of -$80.4M in fiscal 2025, with earnings per share of -$2.01. Revenue grew 436.5% from the prior year.

Is CAMP4 Therapeutics in the Russell 2000?

Yes. CAMP4 Therapeutics Corporation (CAMP) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did CAMP4 Therapeutics go public?

CAMP4 Therapeutics stock began trading on October 11, 2024.

Russell 2000 Biotechnology stocks

All Russell 2000 →